BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ER, estrogen receptor
33510 results:

  • 1. Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes.
    Ping J; Jia G; Cai Q; Guo X; Tao R; Ambrosone C; Huo D; Ambs S; Barnard ME; Chen Y; Garcia-Closas M; Gu J; Hu JJ; John EM; Li CI; Nathanson K; Nemesure B; Olopade OI; Pal T; Press MF; Sanderson M; Sandler DP; Yoshimatsu T; Adejumo PO; Ahearn T; Brewster AM; Hennis AJM; Makumbi T; Ndom P; O'Brien KM; Olshan AF; Oluwasanu MM; Reid S; Yao S; Butler EN; Huang M; Ntekim A; Li B; Troester MA; Palmer JR; Haiman CA; Long J; Zheng W
    Nat Commun; 2024 May; 15(1):3718. PubMed ID: 38697998
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epigenetic Control of cancer Cell Dormancy and Awakening in Endocrine Therapy Resistance.
    Llinas-Bertran A; Bellet-Ezquerra M; Seoane JA
    Cancer Discov; 2024 May; 14(5):704-706. PubMed ID: 38690600
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
    Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
    Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
    [No Abstract]    [Full Text] [Related]  

  • 4. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
    Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
    Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With breast cancer and Positive Axillary Lymph Nodes.
    Cipolla C; Lupo S; Grassi N; Battaglia MC; Mesi C; Scandurra G; Gebbia V; Valerio MR
    Anticancer Res; 2024 May; 44(5):2047-2053. PubMed ID: 38677748
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant breast cancer Stem Cells.
    Robert S; Roman Ortiz NI; LaRocca CJ; Ostrander JH; Davydova J
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675909
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. breast cancer in Patients with Previous Endometriosis Showed Low Aggressive Subtype.
    Vanni G; Selntigia A; Marsella VE; Russo C; Pellicciaro M; Materazzo M; Rizzo G; Buonomo OC; Exacoustos C
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674271
    [No Abstract]    [Full Text] [Related]  

  • 8. A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes.
    Yang L; Zhao X; Yang L; Chang Y; Cao C; Li X; Wang Q; Song Z
    Sci Rep; 2024 Apr; 14(1):9596. PubMed ID: 38671007
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The evolvement of breast cancer therapies: What we have done and where all these head off.
    Nurlaila I; Pambudi S
    Saudi Med J; 2024 Apr; 45(4):331-340. PubMed ID: 38657992
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Not Available].
    Lokøy IK; Bakken IS; Wik E; Stefansson IM
    Tidsskr Nor Laegeforen; 2024 Apr; 144(5):. PubMed ID: 38651722
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D breast or Ovarian cancer.
    Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
    JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Case Report of Occult breast cancer with Triple Negative Subtype].
    Tanaka Y; Ohshima Y; Fukaya Y; Hosoya K; Wakahara M
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):421-423. PubMed ID: 38644310
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer.
    Xiao CK; Ren Y; Chen Q; Yang Y; Tang L; Xu L; Ren Z
    Epigenetics; 2024 Dec; 19(1):2343593. PubMed ID: 38643489
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Community cohesion looseness in gene networks reveals individualized drug targets and resistance.
    Wang S; Lee D
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38622359
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.
    Rymbai E; Sugumar D; Chakkittukandiyil A; Kothandan R; Selvaraj D
    Cell Biochem Funct; 2024 Apr; 42(3):e4014. PubMed ID: 38616346
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
    Bahador M; Saeedi Nejad M; Dabiri S; Larizadeh MH; Soofiabadi MF
    J Egypt Natl Canc Inst; 2024 Apr; 36(1):12. PubMed ID: 38616231
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between estrogen receptor alpha and aryl hydrocarbon receptor gene polymorphisms in the prognosis of breast cancer in Egypt.
    Aboelroos SA; Eltamany EHM; Mohamed FAM; Suliman MA
    Egypt J Immunol; 2024 Apr; 31(2):87-92. PubMed ID: 38615265
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
    Gill J; Yendamuri K; Chatterjee U; Yao S; Oladeru OT; Singh AK; Ma SJ
    BMC Cancer; 2024 Apr; 24(1):461. PubMed ID: 38614979
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Vitamin D receptor as a Prognostic Marker in breast cancer-A Cohort Study.
    Huss L; Gulz-Haake I; Nilsson E; Tryggvadottir H; Nilsson L; Nodin B; Jirström K; Isaksson K; Jernström H
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612962
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1676.